Arrowhead Pharmaceuticals PT Raised to 34.00 - MarketBeat
| HDP1 Stock | EUR 19.00 0.41 2.21% |
Roughly 55% of Arrowhead Pharmaceuticals' stockholders are presently thinking to get in. The analysis of current outlook of investing in Arrowhead Pharmaceuticals suggests that some traders are interested regarding Arrowhead Pharmaceuticals' prospects. The current market sentiment, together with Arrowhead Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Arrowhead Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Arrowhead Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Arrowhead daily returns and investor perception about the current price of Arrowhead Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Arrowhead |
Arrowhead Pharmaceuticals PT Raised to 34.00 MarketBeat
Read at news.google.com
 |
Arrowhead Pharmaceuticals Fundamental Analysis
We analyze Arrowhead Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arrowhead Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arrowhead Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Arrowhead Pharmaceuticals is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Arrowhead Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arrowhead Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Arrowhead Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Arrowhead Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Arrowhead Pharmaceuticals Related Equities
| 2T8 | Townsquare Media | 3.39 | ||||
| S4M | STORE ELECTRONIC | 3.37 | ||||
| NXZ | Nexstar Media | 2.34 | ||||
| UEN | Ubisoft Entertainment | 2.18 | ||||
| ERT | Electronic Arts | 0.51 | ||||
| AS7 | ANTA SPORTS | 0.83 | ||||
| NEN | Renesas Electronics | 2.66 | ||||
| 7TT | TT Electronics | 6.61 |
Complementary Tools for Arrowhead Stock analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |